Lettere - 23/04/2021
Agreement between two commercially available SARS-CoV-2 serologic tests among Italian healthcare workers
Valutazione della concordanza di test sierologici per l’identificazione di SARS-CoV-2 nell’ambito della sorveglianza sierologica degli operatori sanitari
After national lockdown in the effort to defeat the COVID-19 outbreak, the gradual reopening of Italy was accompanied by a series of measures to limit the infection, including extensive epidemiological surveillance by means of antibody testing on selected risk groups.1 The Regional Council of Lombardy Region (Northern Italy), one of the areas most affected by COVID-19 on a global scale, initially authorized DiaSorin as the only provider of SARS-CoV-2 serologic test for diagnostic and epidemiolog…